Żelazo w neurodegeneracji

• Authors: Jolanta Gałązka-Friedman , Andrzej Friedman

Title variants

EN

Iron in neurodegenerative diseases

• Languages of publication: PL EN

Abstracts

PL

W pracy omówiono możliwą rolę żelaza w powstawaniu chorób neurodegeneracyjnych, takich jak choroba Parkinsona, choroba Alzheimera i postępujące porażenie nadjądrowe (PSP). Otrzymane wyniki sugerują różne mechanizmy prowadzące do śmierci komórek nerwowych w tych chorobach.

EN

In this review we discuss the possible role of iron in induction of neurodegenerative disease like Parkinson's disease, Alzheimer disease and progressive supranuclear palsy (PSP). Our results suggest different mechanisms leading to nervous cells death in these diseases.

• Journal: Kosmos
• Year: 2014
• Volume: 63
• Issue: 3
• Pages: 325-330

Dates

published

2014

Contributors

author

Jolanta Gałązka-Friedman

• Wydział Fizyki, Politechnika Warszawska, Koszykowa 75, 00-662 Warszawa, Polska

author

Andrzej Friedman

• Klinika Neurologii, Warszawski Uniwersytet Medyczny, Kondratowicza 8, 03-242 Warszawa, Polska

References

• Bauminger E. R., Barcikowska M., Friedman A., Galazka-Friedman J., Hechel D., Nowik I., 1994. Does iron play a role in Parkinson's disease? Hyperfin. Interact. 91, 853-856.
• Earle K. M., 1968. Studies on Parkinson's disease including X-ray fluorescent spectroscopy of formalin fixed brain tissue. J. Neuropathol. Exp. Neurol. 27, 1-13.
• Friedman A., Arosio P., Finazzi D., Koziorowski D., Galazka-Friedman J., 2011. Ferritin as an important player in neurodegeneration. Park. Rel. Disord. 17, 423-430.
• Galazka-Friedman J., Friedman A., 1997. Controversies about iron in parkinsonian and control substantia nigra. Acta Neurobiol. Exp. 57, 210-225.
• Galazka-Friedman J., Bauminger E. R., Friedman A., Barcikowska M., Hechel D., Nowik I., 1996. Iron in parkinsonian and control substantia nigra - a M(o)ssbauer spectroscopy study. Mov. Disord. 11, 8-16.
• Galazka-Friedman J., Friedman A., Bauminger E. R., 2009a. Iron in the brain. Hyperfine Interact. 189, 31-37.
• Galazka-Friedman J., Bauminger E. R., Szlachta K., Schweitzer K., Wszolek Z., Dickson D., Friedman A., 2009b. Mössbauer studies of pathological brain tissues affected by PSP disease. Acta Phys. Pol. 115, 431-433.
• Galazka-Friedman J., Bauminger E. R., Szlachta K., Koziorowski D., Tomasiuk R., Jaklewicz A., Wszolek Z.K., Dickson D., Kaplinska K., Friedman A., 2011. Iron in Alzheimer and control hippocampi - Mössbauer, atomic absorption and ELISA studies. Acta Phys. Pol. 119, 81-83.
• Galazka-Friedman J., Bauminger E. R., Friedman A., 2013 Iron in neurodegeneration. [W:] Mössbauer spectroscopy- Applications in chemistry, biology and nanotechnology. Sharma V. K., Klingelhöfer G., Nishida T. (red.). Wiley, Hoboken New Jersey, 324-332.
• Griffiths P. D., Crossman A. R., 1993. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. Dementia 4, 61-65.
• Jellinger K., Kienzl E., Rumpelmair G., Riederer P., Stachelberger H., Ben-Shachar D., Youdim M. B. H., 1992. Iron-melanin complex in substantia nigra of parkinsonian brains: an Xray microanalysis. J. Neurochem. 59, 1168-1171.
• Koziorowski D., Friedman A., Arosio P., Santambrogio P., Dziewulska D., 2007. ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and Incidental Lewy Body compared to control. Park. Rel. Disord. 13, 214-218.
• Loeffler D. A., Connor J. R., Juneau P. L., Snyder B. S., Kanaley L., DeMaggio A. J., Nguyen H., Brickman C. M., LeWitt P. A., 1995. Transferrin and iron in normal. Alzheimer's disease. and Parkinson's disease brain regions. J. Neurochem. 65, 710-716.
• Mann V. M., Cooper J. M., Daniel S. E., Srai K., Jenner O., Marsden C. D., Schapira A. H. V., 1994. Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann. Neurol. 36, 876-881.
• Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G. P., Hebenstreit G., Youdim M. B. H., 1988. Increased iron (111) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural. Trans. 74, 199-205.
• Wypijewska A., Galazka-Friedman J., Bauminger E. R., Wszolek Z. K., Schweitzer K. J., Dickson D. W., Jaklewicz A., Elbaum D., Friedman A., 2010. Iron and reactive oxygen species activity in parkinsonian substantia nigra. Park. Rel. Disord. 16, 329-333.